Topics :: medicine
1 thru 10 of 30
Born with a heart defect, 16-month-old Esther Perez was on the brink of life and death. But surgeons at a Los Angeles hospital stepped in, using a 3D-printed heart.
The recent approval of ViiV Healthcare's once-daily, single-tablet anti-HIV regimen, Triumeq, will mean that the market monopoly currently held by Gilead Sciences will soon come to an end.
The high cost of an innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is causing skepticism from some health care providers.
Britain is inviting the public to weigh in on draft rules allowing scientists to create embryos using DNA from three people -- a man and two women -- to prevent mothers from passing on potentially fatal genetic diseases.
The nation’s first new heart disease prevention guidelines in a decade focus more broadly on risk and moving away from specific targets for cholesterol.
The D.C. Council is poised to approve a bill that would decriminalize possession of small amounts of pot, and Democratic Mayor Vincent Gray announced last month that he supports it. He could sign the bill into law as early as January.
California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers announced Tuesday.
Future doctors aren’t learning much about the unique health needs of gays and lesbians, a survey of medical school deans suggests.
Abbott Laboratories says it is withdrawing its diet pill Meridia in the U.S. and Canada, almost a year after studies showed the drug increases the risk of heart attack and stroke in patients with a history of heart disease.
An appeals court ruled Tuesday that government funding of embryonic stem cell research can continue for now.
1 thru 10 of 30